NCT07102628: Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
- State
- Under way
- Phase
- Phase 3
- People
- 305 taking part
- Started
- 3 Oct 2025
- Primary completion
- 16 Jan 2027
- Arms
- Inclisiran sodium 300 mg s.c. + Standard treatment
- Results
- None posted
- 4 Aug 2025: Trial registered
- 3 Oct 2025: Trial started